Pleuropulmonary blastoma

WikiDoc Resources for Pleuropulmonary blastoma
Articles
Most recent articles on Pleuropulmonary blastoma Most cited articles on Pleuropulmonary blastoma Review articles on Pleuropulmonary blastoma Articles on Pleuropulmonary blastoma in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pleuropulmonary blastoma Images of Pleuropulmonary blastoma Photos of Pleuropulmonary blastoma Podcasts & MP3s on Pleuropulmonary blastoma Videos on Pleuropulmonary blastoma
Evidence Based Medicine
Cochrane Collaboration on Pleuropulmonary blastoma Bandolier on Pleuropulmonary blastoma TRIP on Pleuropulmonary blastoma
Clinical Trials
Ongoing Trials on Pleuropulmonary blastoma at Clinical Trials.gov Trial results on Pleuropulmonary blastoma Clinical Trials on Pleuropulmonary blastoma at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pleuropulmonary blastoma NICE Guidance on Pleuropulmonary blastoma NHS PRODIGY Guidance FDA on Pleuropulmonary blastoma CDC on Pleuropulmonary blastoma
Books
Books on Pleuropulmonary blastoma
News
Pleuropulmonary blastoma in the news Be alerted to news on Pleuropulmonary blastoma News trends on Pleuropulmonary blastoma
Commentary
Blogs on Pleuropulmonary blastoma
Definitions
Definitions of Pleuropulmonary blastoma
Patient Resources / Community
Patient resources on Pleuropulmonary blastoma Discussion groups on Pleuropulmonary blastoma Patient Handouts on Pleuropulmonary blastoma Directions to Hospitals Treating Pleuropulmonary blastoma Risk calculators and risk factors for Pleuropulmonary blastoma
Healthcare Provider Resources
Symptoms of Pleuropulmonary blastoma Causes & Risk Factors for Pleuropulmonary blastoma Diagnostic studies for Pleuropulmonary blastoma Treatment of Pleuropulmonary blastoma
Continuing Medical Education (CME)
CME Programs on Pleuropulmonary blastoma
International
Pleuropulmonary blastoma en Espanol Pleuropulmonary blastoma en Francais
Business
Pleuropulmonary blastoma in the Marketplace Patents on Pleuropulmonary blastoma
Experimental / Informatics
List of terms related to Pleuropulmonary blastoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2] Maria Fernanda Villarreal, M.D. [3]

Synonyms and keywords: Pulmonary blastoma

Historical Perspective

• Pleuropulmonary blastoma was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

• Pleuropulmonary blastoma may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Causes

• Pleuropulmonary blastoma may be caused by either [cause1], [cause2], or [cause3].
• Pleuropulmonary blastoma is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for [disease name].

Differentiating [disease name] from other Diseases

• Pleuropulmonary blastoma must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop [disease name].

• Pleuropulmonary blastoma is more commonly observed among patients aged [age range] years old.
• Pleuropulmonary blastoma is more commonly observed among [elderly patients/young patients/children].

Gender

• Pleuropulmonary blastoma affects men and women equally.

• [Gender 1] are more commonly affected with [disease name] than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for [disease name].

• Pleuropulmonary blastoma usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop [disease name].

Risk Factors

• Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with [disease name] remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Pleuropulmonary blastoma is usually asymptomatic.
• Symptoms of [disease name] may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with [disease name] usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with [disease name].

• [Imaging study 1] is the imaging modality of choice for [disease name].
• On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Pleuropulmonary blastoma may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.

• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for [disease name].
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
• [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

• There are no primary preventive measures available for [disease name].

• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].